Cargando…

Cross-Presenting XCR1(+) Dendritic Cells as Targets for Cancer Immunotherapy

The use of dendritic cells (DCs) to generate effective anti-tumor T cell immunity has garnered much attention over the last thirty-plus years. Despite this, limited clinical benefit has been demonstrated thus far. There has been a revival of interest in DC-based treatment strategies following the re...

Descripción completa

Detalles Bibliográficos
Autores principales: Audsley, Katherine M., McDonnell, Alison M., Waithman, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140519/
https://www.ncbi.nlm.nih.gov/pubmed/32121071
http://dx.doi.org/10.3390/cells9030565